INLIF LIMITED Announces Pricing of US$8 Million Initial Public Offering
INLIF , a manufacturer of injection molding machine-dedicated manipulator arms, has announced the pricing of its initial public offering (IPO) of 2,000,000 ordinary shares at $4.00 per share. The company expects to raise $8 million in gross proceeds and will begin trading on the Nasdaq Capital Market under the symbol 'INLF' on January 2, 2025.
The underwriters have a 45-day option to purchase an additional 300,000 shares. Proceeds will fund the construction of a 5G digital intelligent equipment production base, establishment of 24 local marketing offices in China, construction of a research center, and working capital. The offering is expected to close around January 3, 2025, with AC Sunshine Securities acting as underwriter.
INLIF, un produttore di bracci manipolatori dedicati alle macchine per iniezione, ha annunciato la quotazione del suo offerta pubblica iniziale (IPO) di 2.000.000 di azioni ordinarie a 4,00 $ per azione. L'azienda prevede di raccogliere 8 milioni di dollari in proventi lordi e inizierà a essere quotata sul Nasdaq Capital Market con il simbolo 'INLF' il 2 gennaio 2025.
Gli underwriter hanno un'opzione di acquisto di ulteriori 300.000 azioni valida per 45 giorni. I proventi finanzieranno la costruzione di una base di produzione di attrezzature intelligenti digitali 5G, la creazione di 24 uffici di marketing locali in Cina, la costruzione di un centro di ricerca e il capitale circolante. Si prevede che l'offerta si chiuda intorno al 3 gennaio 2025, con AC Sunshine Securities che funge da underwriter.
INLIF, un fabricante de brazos manipuladores dedicados a máquinas de moldeo por inyección, ha anunciado el precio de su oferta pública inicial (IPO) de 2.000.000 de acciones ordinarias a 4,00 $ por acción. La empresa espera recaudar 8 millones de dólares en ingresos brutos y comenzará a cotizar en el Nasdaq Capital Market con el símbolo 'INLF' el 2 de enero de 2025.
Los suscriptores tienen una opción de 45 días para comprar 300.000 acciones adicionales. Los ingresos se destinarán a la construcción de una base de producción de equipos inteligentes digitales 5G, el establecimiento de 24 oficinas de marketing locales en China, la construcción de un centro de investigación y capital de trabajo. Se espera que la oferta cierre alrededor del 3 de enero de 2025, con AC Sunshine Securities actuando como suscriptor.
INLIF는 사출 성형 기계 전용 조작 팔 제조업체로서 상장공모(IPO)를 통해 2,000,000주의 보통주를 주당 4.00달러에 가격을 책정했습니다. 이 회사는 800만 달러의 총 수익을 올릴 것으로 예상하며, 2025년 1월 2일 'INLF'라는 심볼로 나스닥 자본 시장에서 거래를 시작할 예정입니다.
인수자들은 추가로 300,000주를 구매할 수 있는 45일 옵션을 보유하고 있습니다. 수익금은 5G 디지털 지능형 장비 생산 기지 건설, 중국 내 24개의 현지 마케팅 사무소 설립, 연구 센터 건설 및 운영 자본에 사용될 예정입니다. 이번 공모는 2025년 1월 3일경에 마감될 것으로 예상되며, AC Sunshine Securities가 인수자로 활동할 것입니다.
INLIF, un fabricant de bras manipulateurs dédiés aux machines de moulage par injection, a annoncé le prix de son offre publique initiale (IPO) de 2.000.000 d'actions ordinaires à 4,00 $ par action. L'entreprise s'attend à lever 8 millions de dollars en produits bruts et commencera à être cotée sur le Nasdaq Capital Market sous le symbole 'INLF' le 2 janvier 2025.
Les souscripteurs ont une option de 45 jours pour acheter 300.000 actions supplémentaires. Les produits financeront la construction d'une base de production d'équipements intelligents numériques 5G, l'établissement de 24 bureaux de marketing locaux en Chine, la construction d'un centre de recherche et le fonds de roulement. L'offre devrait se clôturer aux alentours du 3 janvier 2025, avec AC Sunshine Securities agissant comme souscripteur.
INLIF, ein Hersteller von manipulativen Armen für Spritzgießmaschinen, hat die Preisgestaltung seines Börsengangs (IPO) für 2.000.000 Stammaktien zu 4,00 $ pro Aktie bekannt gegeben. Das Unternehmen erwartet, 8 Millionen Dollar an Bruttoerlösen zu erzielen und wird am 2. Januar 2025 unter dem Symbol 'INLF' am Nasdaq Capital Market gehandelt.
Die Underwriter haben eine 45-tägige Option, zusätzliche 300.000 Aktien zu kaufen. Die Erlöse werden für den Bau einer Produktionsbasis für digitale intelligente 5G-Ausrüstungen, die Einrichtung von 24 lokalen Marketingbüros in China, den Bau eines Forschungszentrums und für Betriebskapital verwendet. Es wird erwartet, dass das Angebot um den 3. Januar 2025 abgeschlossen wird, wobei AC Sunshine Securities als Underwriter fungiert.
- IPO will raise $8 million in gross proceeds
- Nasdaq Capital Market listing approval secured
- Clear allocation of funds for expansion and R&D
- 45-day option for additional 300,000 shares could increase proceeds
- Potential shareholder dilution from IPO
- Additional dilution possible if 300,000 share option is exercised
Insights
Quanzhou, China, Dec. 31, 2024 (GLOBE NEWSWIRE) -- INLIF LIMITED (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced the pricing of its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of US
The Company expects to receive aggregate gross proceeds of US
Proceeds from the Offering will be used for (i) the construction of a 5G digital intelligent equipment production base; (ii) establishing 24 local marketing and service offices within the PRC; (iii) the construction of an industrial robot and automation application technology research and development center; and (iv) working capital.
The Offering is being conducted on a firm commitment basis. AC Sunshine Securities LLC acted as underwriter for the Offering (the “Underwriter”). Hunter Taubman Fischer & Li LLC is acting as U.S. securities counsel to the Company, and iTKG Law LLC is acting as U.S. counsel to the Underwriter in connection with the Offering.
A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the “SEC”) (File Number: 333-279569) and was declared effective by the SEC on December 20, 2024. The Offering is being made only by means of a prospectus, forming a part of the registration statement. Copies of the prospectus relating to the Offering may be obtained from AC Sunshine Securities LLC, Attn: 200 E. Robinson Street, Suite 295, Orlando, FL 32801, or by email at prospectus@acsunshine.com, or by calling +1(689)-867-6218. In addition, copies of the prospectus relating to the Offering may be obtained via the SEC’s website at www.sec.gov.
Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About INLIF LIMITED
Through its PRC operating entity, Ewatt Robot Equipment Co. Ltd., established in September 2016, INLIF is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. It is also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The Company produces an extensive portfolio of injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, all developed by itself. For more information, please visit the Company’s website: ir.yiwate88.com.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Registration Statement filed with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
INLIF LIMITED
Investor Relations Department
Email: ir@yiwate88.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
What is the IPO price for INLF shares?
When will INLF begin trading on Nasdaq?
How many shares is INLF offering in its IPO?
How will INLF use the IPO proceeds?
What is the total expected gross proceeds from INLF's IPO?